Pierre P. Massion

Scientific Advisor at LUNGevity Foundation

Because there currently is no wide-spread, cost-effective diagnostic for lung cancer, he has spent years immersed in the details of lung cancer in order to devise a method of finding early stage lung cancer before it becomes fatal.